Objective: We report a case of deafness occurring in a temporal context of an influenza vaccination in a 79-year-old woman. Methods: Case report and review of the literature on influenza causing deafness. Results: A 79-year-old woman with normal hearing developed acute bilateral sensorineural hearing loss two days after a seasonal influenza vaccination, other obvious reasons for acute hearing loss were excluded. Conclusion: This patient appears to be the first reported case of bilateral deafness following a trivalent seasonal influenza vaccination.
Introduction
Sudden sensorineural hearing loss (SSNHL) is defined as a minimum of 30 dB hearing loss over 3 consecutive frequencies in a pure tone audiogram, occurring in less than 3 days (1) . While the aetiology of the more common unilateral SSNHL (uni-SSNHL) is idiopathic in over 90 percent of cases (5) , bilateral SSNHL (bi-SSNHL) can be caused by inflammation of the eighth cranial nerve (2) due to local hypersensitivity response and antigen-antibody reaction caused by viral infections, vascular diseases, Meniere's disease, neoplasia (2) , systemic diseases like hypertension, immune reactions following vaccination as seen in cases of hepatitis B-, mumpsand tetanus and diphtheria vaccination, toxic factors (15) and round window membrane rupture (10).
Our case report describes the first adult patient to develop bilateral deafness in a temporal context of a trivalent influenza vaccination containing inactivated influenza virus surface antigens.
Patient Presentation
Two weeks after an influenza vaccination, a 79-year-old woman presented at the ER of a teaching hospital of the University Rostock, Germany, with sudden bilateral deafness, vertigo, headache and impaired balance. She had a history of insulin-dependent diabetes mellitus and atrial fibrillation, and had suffered a right-sided thalamic stroke 37 years before. Two days after the patient received a seasonal influenza vaccination with Xanaflu®, she experienced acute Influenza infection can cause bilateral profound non-reversible deafness, as seen in a two-yearold girl who became deaf two months after suffering bronchopneumonia caused by influenza A (H1N1) (6) . Sudden right ear sensorineural hearing loss and a sensation of fullness in the ear, both occurring on the fourth day of H1N1 infection, were reported in a 73-year-old man. After 24 hours of treatment with prednisolone 60 mg daily, the symptoms improved markedly, and he recovered completely when prednisolone was tapered out gradually over the next few weeks (10).
Hearing impairment due to vaccination has been reported in patients who received vaccines containing live attenuated strains of measles and mumps (12) , and in one case, fluctuant unilateral sensorineural hearing loss with tinnitus was reported after hepatitis B vaccination, with full recovery after 6 months (13). Xanaflu® is a suspension containing the inactivated surface antigens, hemagglutinin and neuraminidase of the influenza virus type A strains H1N1 and H3N2, and of the type B strain, plus traces of egg, formaldehyde, cetrimonium, polysorbate and gentamicin (3). Systemic Gentamicin is the most common cause of iatrogenic ototoxicity, which manifests as bilateral vestibular loss and imbalance (4).
Since obvious viral infections and systemic diseases could be ruled out in our patient, her bilateral deafness might be caused by an undetected infection or disease, or speculatively may be A c c e p t e d M a n u s c r i p t related to influenza vaccination. A toxic effect of gentamicin on the cochlea seems very unlikely, because it is traces of gentamicin.
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